INRAE, Evolugate Enter Option License Agreement to Advance Probiotics to Manage Human Cholesterol

INRAE, Evolugate Enter Option License Agreement to Advance probiotics to manage human cholesterol (Paris, May 27, 2020) INRAE, is pleased to announce that it has entered into an exclusive option license agreement with biotechnology company Evolugate of Gainesville, FL to optimize its probiotic to manage human hypercholesterolemia, a major risk factor for cardiovascular diseases. INRAE … Continue reading INRAE, Evolugate Enter Option License Agreement to Advance Probiotics to Manage Human Cholesterol

Pluton Biosciences, Evolugate Enter License Agreement to Advance Bacterial Strains for Commercial Biopesticide Development

  May 13, 2020 Pluton Biosciences, LLC is pleased to announce that it has entered into an exclusive license agreement with biotechnology company Evolugate of Gainesville, FL to optimize its mosquito biopesticide discovery for commercial use in the vector control industry. Headquartered in St. Louis, MO, Pluton Biosciences discovers new beneficial microbes in the soil … Continue reading Pluton Biosciences, Evolugate Enter License Agreement to Advance Bacterial Strains for Commercial Biopesticide Development

BMC Biotechnology Publication

August 26, 2009 : Publication. The open access journal BMC Biotechnology published a collaborative study between EVOLUGATE, LLC and scientists at the UNIVERSITY OF FLORIDA that discloses the first use of our technology to experimentally evolve industrially important filamentous fungi, which are among the most widely used microorganisms for industrial applications. In this case, the goal … Continue reading BMC Biotechnology Publication

UF collaboration

April 2005 : Collaboration agreement. Evolugate entered into an academic collaboration agreement with University of Florida to help academic laboratories select more efficient micro-organisms using our continuous culture technology.